Joost Neijssen

2 Patents

• US122470772025

  Bispecific Egfr/c-met Antibodies

  Janssen Biotech, Inc.

  0 cites
• US119326932024

  Monoclonal Antibodies Directed Against Programmed Death-1 Protein and Their Use in Medicine

  Genmab A/S

  0 cites